Home › Sezary Syndrome › Missouri
Sezary Syndrome clinical trials in Missouri
3 studies for Sezary Syndrome are looking for participants at sites in Missouri.
Cities in Missouri
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
- Siteman Cancer Center at Washington University, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07003100A Registry for People With T-cell Lymphoma
- Washington University (Data Collection Only), St Louis
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.